Gayn Erickson
President and CEO at Aehr Test Systems
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Aehr Test Systems, 3 years.
Aehr Test Systems
Director · President and CEO
Chief executive roles
Aehr Test Systems
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 27, 2025 | Aehr Test Systems | Shares withheld for tax | −596 | $11.88 | $7,080 |
| Jan 14, 2025 | Aehr Test Systems | Shares withheld for tax | −1,997 | $11.66 | $23,285 |
| Jan 13, 2025 | Aehr Test Systems | Shares withheld for tax | −3,972 | $15.99 | $63,512 |
| Oct 27, 2024 | Aehr Test Systems | Shares withheld for tax | −564 | $15.84 | $8,934 |
| Oct 14, 2024 | Aehr Test Systems | Shares withheld for tax | −2,435 | $15.66 | $38,132 |
| Oct 13, 2024 | Aehr Test Systems | Shares withheld for tax | −1,154 | $15.66 | $18,072 |
| Oct 11, 2024 | Aehr Test Systems | Shares withheld for tax | −2,346 | $16.02 | $37,583 |
| Sep 16, 2024 | Aehr Test Systems | Option exercise | +16,251 | $1.64 | $26,652 |
| Sep 16, 2024 | Aehr Test Systems | Option exercise | +3,338 | $1.64 | $5,474 |
| Jul 29, 2024 | Aehr Test Systems | Shares withheld for tax | −563 | $18.54 | $10,438 |
| Jul 14, 2024 | Aehr Test Systems | Shares withheld for tax | −3,570 | $16.43 | $58,655 |
| Jul 13, 2024 | Aehr Test Systems | Shares withheld for tax | −1,154 | $16.43 | $18,960 |
| Jul 11, 2024 | Aehr Test Systems | Grant or award | +63,931 | — | — |
| Jul 11, 2024 | Aehr Test Systems | Shares withheld for tax | −920 | $15.11 | $13,901 |
| Apr 29, 2024 | Aehr Test Systems | Shares withheld for tax | −546 | $12.10 | $6,607 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.